Rituximab versus cyclophosphamide for the treatment of connective tissue disease associated interstitial lung disease (RECITAL): a randomised controlled trial - Tsipouri, V; Saunders, P; Keir, GJ; Ashby, D; Fletcher, SV; Gibbons, M; Szigeti, M; Parfrey, H; Renzoni, EA; Denton, CP (BIOMED CENTRAL LTD, 2017)